Literature DB >> 15844706

Differential labeling by monoclonal antibodies Adnab-9 and anti-alpha-defensin 5 based on the distribution and adenomatous tissue content of colonic polyps.

Nadeem Ullah1, Kashif Qureshi, Violeta Yordanova, James Hatfield, Paula Sochacki, Michael Lawson, Martin Tobi.   

Abstract

We sought a correlation between site and morphology of colonic polyps by labeling with neoplastic and general Paneth cell markers, monoclonal antibodies Adnab-9 and anti-alpha-defensin 5, respectively. Proportions labeled by Adnab-9 and anti-alpha-defensin 5 were, respectively, 42 and 85% for adenomas, 39 and 63% for early tubular adenomas, 41 and 44% for serrated, 34 and 20% for mixed, and 11 versus 2.7% for hyperplastic polyps. Compared with hyperplastic polyps, the proportion of other polyps labeled by Adnab-9 or anti-alpha-defensin 5 was higher but this difference was more significant for distal (P = 0.008 for Adnab-9 and P = 0.0001 for anti-alpha-defensin 5) than proximal (P = 0.645 and P = 0.154, respectively) polyps. While increased labeling of all proximal polyps compared to distal ones mirrored the colonic distribution of Paneth cells, distal adenomas tended to have a higher proportion labeled by Adnab-9, suggesting that Adnab-9 labels Paneth cells associated with increased neoplastic potential.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15844706     DOI: 10.1007/s10620-005-2561-5

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  36 in total

1.  A simple method to demonstrate normal and metaplastic Paneth cells in tissue sections.

Authors:  C A Rubio; G Nesi
Journal:  In Vivo       Date:  2003 Jan-Feb       Impact factor: 2.155

2.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

3.  Spatial distribution and histogenesis of colorectal Paneth cell metaplasia in idiopathic inflammatory bowel disease.

Authors:  M Tanaka; H Saito; T Kusumi; S Fukuda; T Shimoyama; Y Sasaki; K Suto; A Munakata; H Kudo
Journal:  J Gastroenterol Hepatol       Date:  2001-12       Impact factor: 4.029

4.  Correlation of Ki-67, p53, and Adnab-9 immunohistochemical staining and ploidy with clinical and histopathologic features of severely dysplastic colorectal adenomas.

Authors:  Rafiq A Sheikh; Byung Hee Min; Shagufta Yasmeen; Raymond Teplitz; Henry Tesluk; Boris Henry Ruebner; Martin Tobi; James Hatfield; Suzanne Fligiel; Michael J Lawson
Journal:  Dig Dis Sci       Date:  2003-01       Impact factor: 3.199

5.  Cell lineage markers in premalignant and malignant colonic mucosa.

Authors:  S B Ho; S H Itzkowitz; A M Friera; S H Jiang; Y S Kim
Journal:  Gastroenterology       Date:  1989-08       Impact factor: 22.682

6.  Detection of gastric cancer and premalignant lesions by novel marker glycoprotein 87 using monoclonal antibody Adnab-9.

Authors:  Shi-Xing Qiao; Mei Yuan; Yia-Li Liu; Xing-Shi Lin; Xiao-Ping Zhang; Martin Tobi
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-10       Impact factor: 4.254

7.  Adenoma-derived antibody, Adnab-9 recognizes a membrane-bound glycoprotein in colonic tissue and effluent material from patients with colorectal neoplasia.

Authors:  M Tobi; B Maliakkal; I Zitron; M Alousi; R Goo; L Nochomovitz; G Luk
Journal:  Cancer Lett       Date:  1992-10-30       Impact factor: 8.679

8.  Incidence of Paneth cells in minute tubular adenomas and adenocarcinomas of the large bowel.

Authors:  R Wada; H Miwa; H Abe; R M Santo; S Kitamura; N Kuwabara; K Suda; K Kondo; S Yamada; T Hamada
Journal:  Acta Pathol Jpn       Date:  1992-08

9.  Cellular distribution of a colonic adenoma-associated antigen as defined by monoclonal antibody Adnab-9.

Authors:  M Tobi; B J Maliakkal; M A Alousi; V Voruganti; M Shafiuddin; S Yang; M S Gesell; T An; J S Hatfield; S Fligiel
Journal:  Scand J Gastroenterol       Date:  1992-09       Impact factor: 2.423

10.  A case-cohort study for the disease natural history of adenoma-carcinoma and de novo carcinoma and surveillance of colon and rectum after polypectomy: implication for efficacy of colonoscopy.

Authors:  C-D Chen; M-F Yen; W-M Wang; J-M Wong; T H-H Chen
Journal:  Br J Cancer       Date:  2003-06-16       Impact factor: 7.640

View more
  1 in total

1.  An anti-adenoma antibody, Adnab-9, may reflect the risk for neoplastic progression in familial hamartomatous polyposis syndromes.

Authors:  Martin Tobi; Michael Kam; Nadeem Ullah; Kashif Qureshi; Violeta Yordanova; James Hatfield; Suzanne E G Fligiel; Paula Sochacki; Thomas McGarrity; Carolyn Cole; Michael Lawson; Russell Jacoby
Journal:  Dig Dis Sci       Date:  2007-10-13       Impact factor: 3.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.